Category General

Compare Semax vs Selank by peptide sequence, structural origin, proposed mechanisms, BDNF and GABA research, evidence quality and key differences.

Compare tesamorelin, CJC-1295 and ipamorelin by peptide class, receptor pathway, duration, pharmacokinetics and strength of published human evidence.

Compare CJC-1295 with DAC, CJC-1295 without DAC and ipamorelin by receptor target, albumin binding, duration, human evidence and research profile.

Understand peptide storage and stability for lyophilized and reconstituted research materials, including temperature, light, moisture, freeze-thaw cycles and handling.

Learn how to read a peptide Certificate of Analysis, including HPLC purity, LC-MS identity, net peptide content, batch verification and common COA red flags.

Is Retatrutide Available in Canada? Yes — retatrutide is available in Canada as a research peptide. As it completes Phase 3 clinical trials globally, it is accessible as a research compound for qualified investigators and laboratory use. For a detailed…

Retatrutide Dosing: A Research Protocol Reference This guide compiles dosing information, reconstitution procedures, and storage guidelines for retatrutide based on published clinical trial literature and standard peptide handling protocols. It is intended as a reference for researchers working with retatrutide…

Retatrutide Clinical Trials: Where We Stand in 2026 Retatrutide (LY3437943) has emerged as one of the most closely watched peptide compounds in metabolic research. Following landmark Phase 2 results published in The New England Journal of Medicine, the compound has…

Comparing Retatrutide, Tirzepatide, and Semaglutide The metabolic peptide research landscape has evolved rapidly with the development of multi-receptor agonists. While semaglutide established the foundation as a single GLP-1 receptor agonist, tirzepatide advanced the field with dual GLP-1/GIP agonism, and now…

What Is Retatrutide? Retatrutide (LY3437943) is a novel triple-agonist peptide developed by Eli Lilly that simultaneously activates three incretin-related receptors. It belongs to one of several types of peptides classified by their receptor targets — in this case, a triple-agonist…